tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Puma Biotechnology Inc

PBYI
Add to Watchlist
7.930USD
+0.040+0.51%
Close 07-31 16:00（ET）Quotes delayed by 15 min
403.63MMarket Cap
16.24P/E TTM

Puma Biotechnology Inc

7.930
+0.040+0.51%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

PBYI Financials

See Puma Biotechnology Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Puma Biotechnology Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/0.04
Revenue / Forecast
--/53.00M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
228.37M
-0.91%
EPS(YoY)
0.62
-0.05%
Analyst Rating
HOLD
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-223.10%-0.07
-32.19%0.27
-57.62%0.18
225.62%0.12
160.01%0.06
52.57%0.39
239.89%0.41
-306.25%-0.09
-432.62%-0.10
310.66%0.26
--0.12
--0.05
--0.03
---0.12
--0.13
----
----
----
----
----
Revenue
-2.59%44.81M
27.72%75.45M
-32.36%54.48M
11.37%52.44M
5.12%46.01M
-18.15%59.08M
43.53%80.54M
-13.72%47.08M
-17.07%43.77M
9.90%72.18M
-1.73%56.12M
-8.32%54.57M
15.39%52.77M
18.64%65.67M
23.48%57.10M
11.49%59.52M
-53.41%45.74M
5.33%55.36M
-8.88%46.24M
-24.37%53.38M
Net Profit
-226.19%-3.75M
-30.39%13.44M
-56.47%8.84M
229.28%5.86M
161.77%2.97M
57.36%19.30M
250.53%20.32M
-313.03%-4.53M
-443.68%-4.81M
318.84%12.27M
1710.00%5.80M
-77.31%2.13M
141.17%1.40M
-232.72%-5.61M
99.19%-360.00K
283.53%9.37M
-120.59%-3.40M
128.17%4.22M
-41.98%-44.67M
-250.40%-5.11M
Net Margin
-229.55%-8.37%
-45.50%17.81%
-35.64%16.23%
216.08%11.17%
158.76%6.46%
92.26%32.68%
144.23%25.23%
-346.90%-9.62%
-514.43%-11.00%
299.12%17.00%
--10.33%
--3.90%
--2.65%
---8.54%
--3.45%
----
----
----
----
----
Gross Margin
-0.41%76.74%
-9.27%69.35%
21.57%77.65%
-1.06%76.54%
2.08%77.06%
15.29%76.44%
-16.32%63.87%
-1.16%77.36%
0.71%75.49%
-10.84%66.30%
--76.33%
--78.27%
--74.95%
--74.36%
--76.44%
----
----
----
----
----
Debt to assets ratio
-79.48%5.86%
-66.87%10.41%
-53.01%16.62%
-47.02%23.02%
-38.91%28.53%
-27.30%31.43%
-27.47%35.37%
-11.97%43.45%
-7.06%46.71%
-2.35%43.23%
--48.77%
--49.36%
--50.25%
--44.27%
--49.30%
----
----
----
----
----
Income Statement
Revenue
-2.59%44.81M
27.72%75.45M
-32.36%54.48M
11.37%52.44M
5.12%46.01M
-18.15%59.08M
43.53%80.54M
-13.72%47.08M
-17.07%43.77M
9.90%72.18M
-1.73%56.12M
-8.32%54.57M
15.39%52.77M
18.64%65.67M
23.48%57.10M
11.49%59.52M
-53.41%45.74M
5.33%55.36M
-8.88%46.24M
-24.37%53.38M
Operating profit
-196.08%-3.83M
27.99%17.11M
-56.64%9.57M
404.54%6.64M
273.29%3.98M
-9.68%13.37M
139.73%22.08M
-144.54%-2.18M
-152.67%-2.30M
47.74%14.80M
-1.95%9.21M
-59.43%4.89M
684.34%4.37M
46.60%10.02M
204.90%9.39M
172.49%12.06M
-103.71%-747.00K
161.28%6.83M
26.19%-8.95M
-333.31%-16.63M
Net Profit
-226.19%-3.75M
-30.39%13.44M
-56.47%8.84M
229.28%5.86M
161.77%2.97M
57.36%19.30M
250.53%20.32M
-313.03%-4.53M
-443.68%-4.81M
318.84%12.27M
1710.00%5.80M
-77.31%2.13M
141.17%1.40M
-232.72%-5.61M
99.19%-360.00K
283.53%9.37M
-120.59%-3.40M
128.17%4.22M
-41.98%-44.67M
-250.40%-5.11M
Balance Sheet
Current assets
7.36%142.26M
10.18%162.69M
-8.44%143.58M
-0.83%136.58M
-7.35%132.51M
-5.46%147.66M
25.10%156.82M
16.17%137.72M
27.98%143.03M
16.31%156.19M
2.45%125.35M
3.74%118.55M
-4.95%111.75M
-4.10%134.28M
-10.64%122.35M
-31.88%114.28M
-28.21%117.57M
-4.19%140.02M
-14.32%136.92M
5.36%167.75M
Total current liabilities
-31.07%59.74M
-15.46%81.25M
-25.06%82.73M
-24.16%79.10M
-11.74%86.66M
-3.29%96.11M
63.89%110.40M
73.00%104.30M
103.77%98.19M
28.26%99.38M
12.29%67.36M
6.08%60.29M
-35.57%48.19M
-29.29%77.48M
-48.40%59.99M
-58.79%56.83M
-46.73%74.79M
-4.09%109.59M
-1.64%116.26M
45.89%137.90M
Total assets
-1.77%192.70M
1.39%216.30M
-8.09%202.86M
-4.92%194.92M
-8.39%196.18M
-7.46%213.33M
8.41%220.72M
2.25%205.00M
9.12%214.15M
3.81%230.53M
2.43%203.60M
3.53%200.49M
-2.21%196.26M
-2.00%222.06M
-12.16%198.77M
-25.52%193.65M
-22.41%200.69M
-7.22%226.59M
-13.53%226.29M
-1.45%260.00M
Total liabilities
-35.12%64.28M
-29.08%85.96M
-41.46%87.59M
-42.36%90.20M
-39.28%99.07M
-31.55%121.21M
-9.24%149.63M
-8.00%156.49M
-4.25%163.17M
-11.66%177.09M
-6.65%164.86M
-2.20%170.09M
-11.95%170.41M
-12.48%200.45M
-25.54%176.62M
-24.56%173.91M
-20.10%193.54M
-8.45%229.03M
-9.51%237.21M
-4.11%230.53M
Total equity
32.24%128.42M
41.48%130.34M
62.15%115.27M
115.87%104.72M
90.48%97.11M
72.38%92.13M
83.49%71.09M
59.57%48.51M
97.25%50.98M
147.33%53.44M
74.87%38.74M
54.01%30.40M
261.75%25.85M
983.40%21.61M
302.85%22.16M
-33.02%19.74M
-56.53%7.14M
58.90%-2.45M
-2311.04%-10.92M
25.92%29.47M
Cash Flow Statement
Net operating income
326.80%15.42M
-7.61%14.42M
-12.22%9.69M
1271.18%14.08M
-67.88%3.61M
49.28%15.61M
3.98%11.04M
-68.84%1.03M
325.50%11.25M
36.08%10.46M
-38.50%10.62M
123.76%3.30M
109.83%2.64M
241.36%7.68M
64.40%17.26M
-18648.65%-13.87M
-271.73%-26.89M
3.55%-5.43M
510.35%10.50M
-100.46%-74.00K
Net investment
61.59%2.47M
-1062.80%-26.98M
95.37%506.00K
-1700.00%-11.25M
108.02%1.53M
71.60%-2.32M
-97.68%259.00K
115.01%703.00K
-9.34%-19.08M
31.19%-8.17M
39.76%11.18M
-334.50%-4.68M
-294.28%-17.45M
-356.94%-11.87M
278.93%8.00M
134.85%2.00M
269.44%8.98M
461.48%4.62M
-73.39%-4.47M
37.83%-5.73M
Net financing
0.00%-11.33M
-0.01%-11.33M
-1.33%-11.33M
1.15%-11.20M
---11.33M
---11.33M
---11.18M
---11.33M
----
-100.00%0.00
100.00%0.00
--0.00
-100.00%0.00
121650.00%2.43M
99.83%-53.00K
--0.00
--9.85M
-108.70%-2.00K
-74353.49%-31.93M
-100.00%0.00

FAQs

What is the total revenue of Puma Biotechnology Inc?

According to Puma Biotechnology Inc's FY2025 earnings report, its total revenue reached 228.37M, with a year-on-year change of 230.47M.

What are the current assets of Puma Biotechnology Inc?

According to Puma Biotechnology Inc's FY2025 earnings report, its current assets were 162.69M, with a year-on-year change of 10.18.

What are the total assets of Puma Biotechnology Inc?

According to Puma Biotechnology Inc's FY2025 earnings report, its total assets of Puma Biotechnology Inc were 216.30M, with a year-on-year change of 1.39.

What are the total liabilities of Puma Biotechnology Inc?

According to Puma Biotechnology Inc's FY2025 earnings report, its total liabilities of Puma Biotechnology Inc were 85.96M, with a year-on-year change of -29.08.

What is the total equity of Puma Biotechnology Inc?

According to Puma Biotechnology Inc's FY2025 earnings report, its total equity of Puma Biotechnology Inc was 130.34M, with a year-on-year change of 41.48.

What is the net operating income of Puma Biotechnology Inc?

According to Puma Biotechnology Inc's FY2025 earnings report, its net operating income of Puma Biotechnology Inc was 37.30M, with a year-on-year change of 20.45.

What is the net investment of Puma Biotechnology Inc?

According to Puma Biotechnology Inc's FY2025 earnings report, its net investment of Puma Biotechnology Inc was -36.19M, with a year-on-year change of -77.06.

What is the net financing of Puma Biotechnology Inc?

According to Puma Biotechnology Inc's FY2025 earnings report, its net financing of Puma Biotechnology Inc was -45.20M, with a year-on-year change of -33.54.

What is the Earnings Per Share (EPS) of Puma Biotechnology Inc?

According to Puma Biotechnology Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 0.62, with a year-on-year change of -0.05.

What is the net income of Puma Biotechnology Inc?

According to Puma Biotechnology Inc's FY2025 earnings report, its net income was 31.11M, with a year-on-year change of 2.75.

What is the net margin of Puma Biotechnology Inc?

According to Puma Biotechnology Inc's FY2025 earnings report, its net profit margin was 13.62, with a year-on-year change of 3.69.

What is the gross margin of Puma Biotechnology Inc?

According to Puma Biotechnology Inc's FY2025 earnings report, its gross margin was 74.53, with a year-on-year change of 3.44.

What is the debt-to-asset ratio of Puma Biotechnology Inc?

According to Puma Biotechnology Inc's FY2025 earnings report, its debt-to-asset ratio was 10.41, with a year-on-year change of -66.87.

What is the Return on Equity (ROE) of Puma Biotechnology Inc?

According to Puma Biotechnology Inc's FY2025 earnings report, its Return on Equity (ROE) was 27.97, with a year-on-year change of -32.77.

What is the Return on Assets (ROA) of Puma Biotechnology Inc?

According to Puma Biotechnology Inc's FY2025 earnings report, its Return on Assets (ROA) was 14.48, with a year-on-year change of 6.15.

What is the operating profit of Puma Biotechnology Inc?

According to Puma Biotechnology Inc's FY2025 earnings report, its operating profit was 37.30M, with a year-on-year change of 20.45.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy